Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX1 | P51575 | 12/20 | 0.77 |
| ▸ | P2RX7 | Q99572 | 6/20 | 0.77 |
| ▸ | P2RX4 | Q99571 | 5/20 | 0.77 |
| ▸ | TMPRSS4 | Q9NRS4 | 3/20 | 0.77 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.70 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | IKBKB | O14920 | 1/20 | 0.62 |
| ▸ | CHUK | O15111 | 1/20 | 0.62 |
| ▸ | KDR | P35968 | 1/20 | 0.62 |
| ▸ | FLT3 | P36888 | 1/20 | 0.62 |
| ▸ | MYLK | Q15746 | 1/20 | 0.62 |
| ▸ | MAP4K5 | Q9Y4K4 | 1/20 | 0.62 |
| ▸ | RORC | P51449 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29891420 | 1.00 | P2RX1 (0.77) | P2RX1P2RX7P2RX4TMPRSS4RXFP1 | |
| SCHEMBL3455896 | 0.88 | RXFP1 (0.88) | P2RX1P2RX7P2RX4TMPRSS4RXFP1 | |
| SCHEMBL14885879 | 0.87 | P2RX1 (1.00) | P2RX1P2RX7P2RX4TMPRSS4RXFP1 | |
| SCHEMBL5369677 | 0.86 | RORC (0.76) | P2RX1P2RX7P2RX4TMPRSS4RXFP1 | |
| SCHEMBL15171235 | 0.84 | TLR8 (0.76) | P2RX1P2RX7P2RX4TMPRSS4RXFP1 | |
| SCHEMBL127962 | 0.83 | P2RX1 (1.00) | P2RX1P2RX7P2RX4TMPRSS4MEN1 | |
| SCHEMBL10797383 | 0.83 | P2RX1 (0.73) | P2RX1P2RX7P2RX4TMPRSS4RXFP1 | |
| SCHEMBL15528915 | 0.83 | RXFP1 (1.00) | RXFP1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL5666099 | 0.82 | P2RX1 (1.00) | P2RX1P2RX7P2RX4TMPRSS4RXFP1 | |
| SCHEMBL26634737 | 0.82 | P2RX1 (0.77) | P2RX1P2RX7P2RX4TMPRSS4RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12623942-B2 | Method for extracting salts and temperature- regenerated extracting composition | ADIONICS (FR) | 2026-05-12 | — | — | US | disclosed |
| CN-113292128-B | Apparatus and method for desalting water by thermal deionization and liquid phase ion extraction | 艾迪奥尼克斯公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20230382775-A1 | METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION | ADIONICS (FR) | 2023-11-30 | — | — | US | disclosed |
| US-11772997-B2 | Method for extracting salts and temperature-regenerated extracting composition | ADIONICS (FR) | 2023-10-03 | — | — | US | disclosed |
| US-11731933-B2 | Device and method for the desalination of water by means of thermal deionisation and liquid-phase ion extraction liquid | ADIONICS (FR) | 2023-08-22 | — | — | US | disclosed |
| CN-113200938-B | Benzisothiazole hypoxia inducible factor 2 agonist compound or pharmaceutically acceptable salt thereof, preparation method and application | 中国药科大学 | 2022-08-26 | — | — | CN | disclosed |
| CN-109641160-B | Method for extracting salt and temperature-regenerated extraction composition | 艾迪奥尼克斯公司 | 2022-02-25 | — | — | CN | disclosed |
| EP-3247677-B1 | LIQUID ORGANIC COMPOSITION FOR ION EXTRACTION IN LIQUID PHASE | ADIONICS (FR) | 2021-12-08 | — | — | EP | disclosed |
| US-20210355076-A1 | DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID | ADIONICS (FR) | 2021-11-18 | — | — | US | disclosed |
| CN-113292128-A | Apparatus and method for desalination of water by thermal deionization and liquid phase ion extraction | 艾迪奥尼克斯公司 | 2021-08-24 | — | — | CN | disclosed |
| CN-113200938-A | Benzisothiazole hypoxia inducible factor 2 agonist compound or pharmaceutically acceptable salt thereof, preparation method and application | 中国药科大学 | 2021-08-03 | — | — | CN | disclosed |
| US-11066356-B2 | Device and method for the desalination of water by means of thermal deionisation and liquid-phase ion extraction liquid | ADIONICS (FR) | 2021-07-20 | — | — | US | disclosed |
| US-20210214254-A1 | METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION | ADIONICS (FR) | 2021-07-15 | — | — | US | disclosed |
| CN-107207288-B | Apparatus and method for desalination of water by thermal deionization and liquid phase ion extraction | 艾迪奥尼克斯公司 | 2021-07-06 | — | — | CN | disclosed |
| EP-3808425-A1 | DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID | ADIONICS (FR) | 2021-04-21 | — | — | EP | disclosed |
| EP-3487597-A1 | METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION | Adionics (FR) | 2019-05-29 | — | — | EP | disclosed |
| CN-109641160-A | Extract the method for salt and the extracts composition of temperature regeneration | 艾迪奥尼克斯公司 | 2019-04-16 | — | — | CN | disclosed |
| US-20180009738-A1 | DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID | ADIONICS (FR) | 2018-01-11 | — | — | US | disclosed |
| EP-3247677-A1 | DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID | ADIONICS (FR) | 2017-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731933-B2 | Device and method for the desalination of water by means of thermal deionisation and liquid-phase ion extraction liquid | AQP3, AQP1, AQP4 | P2RX1 2832/4885P2RX7 2431/4885P2RX4 2933/4885 |
| US-20210355076-A1 | DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID | AQP3, AQP1, AQP4 | P2RX1 2832/4885P2RX7 2431/4885P2RX4 2933/4885 |
| US-12623942-B2 | Method for extracting salts and temperature- regenerated extracting composition | POLQ, NONO, AQP3 | P2RX1 2777/4885P2RX7 2083/4885P2RX4 2605/4885 |
| US-20180009738-A1 | DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID | AQP3, AQP1, AQP4 | P2RX1 2832/4885P2RX7 2431/4885P2RX4 2933/4885 |
| US-11066356-B2 | Device and method for the desalination of water by means of thermal deionisation and liquid-phase ion extraction liquid | AQP3, AQP1, AQP4 | P2RX1 2832/4885P2RX7 2431/4885P2RX4 2933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.